Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome

AIM: This study sought to clarify the usefulness of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC). METHODS: The subjects were 69 patients with HCC receiving lenvatinib; the median age was 73 years, and 14 and 67 patients had been previously treated with regorafenib and/or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Fuchigami, Akira, Imai, Yukinori, Uchida, Yoshihito, Uchiya, Hiroshi, Fujii, Yohei, Nakazawa, Manabu, Ando, Satsuki, Sugawara, Kayoko, Nakayama, Nobuaki, Tomiya, Tomoaki, Mochida, Satoshi
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147769/
https://ncbi.nlm.nih.gov/pubmed/32275701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0231427
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados